Clinical Trials
3 trialsNCT02346955 2020-08-27
MK-6018-001
KitovPharma
Phase 1 Terminated
NCT00399113 2011-07-14
Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
PainT
Phase 1 Completed
NCT00734188 2011-07-14
Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
PainT
Phase 1 Completed